title: Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels.
abstract: The spectral changes of native fluorophores among normal fibroblasts and cancer cell lines of different metastatic ability are investigated by fluorescence spectroscopy. The normal (fibroblast), moderately metastatic (DU-145), and advanced metastatic (PC-3) cell lines were each selectively excited at 300 nm, and their fluorescence emission spectra are analyzed using principal component analysis to explore the differences of the relative contents of tryptophan and reduced nicotinamide adenine dinucleotide in these cell lines. The results show that the tryptophan emission featured predominantly in the fluorescence spectra of the advanced metastatic cancer cells in comparison with the moderately metastatic cancer and normal cells.
authors.affiliation: City College of the City University of New York, Institute for Ultrafast Spectroscopy and Lasers, Department of Physics, New York, New York 10031, USA.
authors.forename: Yang
authors.initials: Y
authors.lastname: Pu
authors.forename: Jianpeng
authors.initials: J
authors.lastname: Xue
authors.forename: Wubao
authors.initials: W
authors.lastname: Wang
authors.forename: Baogang
authors.initials: B
authors.lastname: Xu
authors.forename: Yueqing
authors.initials: Y
authors.lastname: Gu
authors.forename: Rui
authors.initials: R
authors.lastname: Tang
authors.forename: Ellen
authors.initials: E
authors.lastname: Ackerstaff
authors.forename: Jason A
authors.initials: JA
authors.lastname: Koutcher
authors.forename: Samuel
authors.initials: S
authors.lastname: Achilefu
authors.forename: Robert R
authors.initials: RR
authors.lastname: Alfano
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D045744:Cell Line, Tumor; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D057054:Molecular Imaging / Q000379:methods*; D009243:NAD / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000737:chemistry* / Q000175:diagnosis*; D015203:Reproducibility of Results; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence / Q000379:methods*; D014364:Tryptophan / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D009243:NAD; D014364:Tryptophan
references.citation: Nature. 2011 Oct 12;478(7368):192-4
references.pmid: 21993754
references.citation: J Biomed Opt. 2012 Aug;17(8):081419
references.pmid: 23224180
references.citation: J Biomed Opt. 2013 Jan;18(1):17005
references.pmid: 23296086
references.citation: Opt Lett. 1990 Nov 1;15(21):1179-81
references.pmid: 19771033
references.citation: J Urol. 2005 Feb;173(2):342-59
references.pmid: 15643172
references.citation: Appl Opt. 2013 Feb 20;52(6):1293-301
references.pmid: 23435002
references.citation: Technol Cancer Res Treat. 2011 Apr;10(2):113-20
references.pmid: 21381789
references.citation: Technol Cancer Res Treat. 2011 Dec;10(6):507-17
references.pmid: 22066592
references.citation: J Biomed Opt. 2010 Jul-Aug;15(4):047008
references.pmid: 20799839
references.citation: Opt Lett. 2012 Aug 15;37(16):3360-2
references.pmid: 23381257
references.citation: FEBS Lett. 2007 May 1;581(9):1793-9
references.pmid: 17416362
references.citation: Bull N Y Acad Med. 1991 Mar-Apr;67(2):143-50
references.pmid: 2049567